SA
NVO

Shilanski & Associates’s Novo Nordisk NVO Stock Holding History

Shilanski & Associates’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,908
Closed -$584K – 112
2024
Q3 		$584K Sell
4,908
-230
-4% -$30.7K 0.19% 61
2024
Q2 		$733K Sell
5,138
-279
-5% -$37K 0.25% 63
2024
Q1 		$698K Buy
5,417
+320
+6% +$38.1K 0.24% 63
2023
Q4 		$527K Sell
5,097
-228
-4% -$22.5K 0.2% 64
2023
Q3 		$484K Sell
5,325
-155
-3% -$13.7K 0.2% 68
2023
Q2 		$443K Buy
5,480
+28
+0.5% +$2.29K 0.18% 73
2023
Q1 		$430K Sell
5,452
-6
-0.1% -$425 0.19% 71
2022
Q4 		$369K Buy
+5,458
New +$320K 0.16% 74
2022
Q3 		– Sell
-5,204
Closed -$290K – 193
2022
Q2 		$290K Buy
5,204
+64
+1% +$3.55K 0.14% 81
2022
Q1 		$287K Buy
5,140
+662
+15% +$34K 0.12% 92
2021
Q4 		$251K Buy
+4,478
New +$243K 0.11% 96

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return